{
  "docId": "019de070-a7f9-700d-9686-c0d9e2559ea7",
  "docSlug": "49e1302a11c2e640ac427a516c932653",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 82 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 45,
  "pageCount": 82,
  "prevPage": 44,
  "nextPage": 46,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 60,
  "notes": "Includes a callout box highlighting a 6% growth in WELLBUTRIN/APLENZIN revenue.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-a7f9-700d-9686-c0d9e2559ea7/45",
  "deckHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7",
  "deckJsonHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7.json",
  "deckAnchorHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7#slide-45",
  "components": [
    {
      "bbox": {
        "h": 0.205,
        "w": 0.225,
        "x": 0.758,
        "y": 0.16
      },
      "kind": "callout",
      "text": "+6% WELLBUTRIN/APLENZIN combined reported revenue growth vs. 4Q19; driven by WELLBUTRIN, which saw 10% reported revenue growth vs. 4Q19",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "acea573a-f7c7-4028-8ea1-51fe52df3a3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.725,
        "x": 0.258,
        "y": 0.915
      },
      "kind": "source-note",
      "text": "1. See Slide 2 and Appendix for further non-GAAP information. 2. See Appendix for further information on the use and calculation of constant currency. 3. Organic growth/change, a non-GAAP metric, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. 4. See the Appendix for details on amortization and impairments of intangible assets 5. U.S. sales only.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49a96b7f-7b16-49aa-8c12-6734ce2e5482",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.755,
        "w": 0.697,
        "x": 0.053,
        "y": 0.158
      },
      "kind": "table",
      "text": "Financial performance table for Diversified Products segment",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "658ee991-2856-442d-8b45-cc0cf85fa9bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.375,
        "x": 0.201,
        "y": 0.065
      },
      "kind": "title",
      "text": "Financial Results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a052af81-7f74-4615-b41f-b3157e554b1d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}